Unknown PHASE4 INTERVENTIONAL 2-arm NCT05008887

Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo

Efficacy of Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo

Sponsor: Assiut University

Conditions Vitiligo

Interventions 5-fluorouracil Fractional CO2 laser Methotrexate

Updated 6 times since 2021 Last updated: May 6, 2022 Started: Sep 30, 2022 Primary completion: Mar 31, 2023 Completion: Apr 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Vitiligo and is currently ongoing. Assiut University leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jun 2024 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Jun 2022 — Jun 2024 [monthly]

Not Yet Recruiting PHASE4
May 2022 — Jun 2022 [monthly]

Not Yet Recruiting PHASE4

▶ Show 1 earlier version

Sep 2021 — May 2022 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.